Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.35 |
| ▸ | GABRR1 | P24046 | 2/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | GRIK1 | P39086 | 3/20 | 0.33 |
| ▸ | GRIA4 | P48058 | 2/20 | 0.33 |
| ▸ | GRIK3 | Q13003 | 2/20 | 0.33 |
| ▸ | GRIK5 | Q16478 | 2/20 | 0.33 |
| ▸ | GRIK2 | Q13002 | 2/20 | 0.33 |
| ▸ | GRM1 | Q13255 | 2/20 | 0.33 |
| ▸ | GRM2 | Q14416 | 2/20 | 0.33 |
| ▸ | GRM8 | O00222 | 1/20 | 0.33 |
| ▸ | GRM6 | O15303 | 1/20 | 0.33 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.33 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.33 |
| ▸ | GSR | P00390 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | GRM5 | P41594 | 1/20 | 0.33 |
| ▸ | GRIA1 | P42261 | 1/20 | 0.33 |
| ▸ | GRIA2 | P42262 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21315720 | 1.00 | TDP1 (0.39) | TDP1SLC22A6GABRR1LMNAGRIK1 | |
| SCHEMBL1653844 | 0.88 | SLC22A6 (0.39) | TDP1SLC22A6GABRR1LMNAGRIK1 | |
| Hydrochloric Acid SCHEMBL11804611 | 0.86 | SLC22A6 (0.38) | TDP1SLC22A6GABRR1LMNAGRIK1 | |
| Aminocarbonyl Dihydrogen Phosphate SCHEMBL21410683 | 0.86 | CA4 (0.50) | GRM8GRM6GRM7GRM4 | |
| SCHEMBL5221873 | 0.84 | ALOX15 (0.33) | CYP1A2ALOX15BLMPMP22KMT2A | |
| SCHEMBL3291829 | 0.82 | ALOX15 (0.32) | ALOX15 | |
| SCHEMBL21315719 | 0.82 | ALOX15 (0.32) | ALOX15 | |
| SCHEMBL28002998 | 0.81 | SLC22A6 (0.38) | TDP1SLC22A6GABRR1LMNAGRIK1 | |
| SCHEMBL62914 | 0.81 | SLC22A6 (0.38) | TDP1SLC22A6GABRR1LMNAGRIK1 | |
| SCHEMBL1824385 | 0.80 | ALOX15 (0.38) | SLC22A6GABRR1LMNAGRIK1GRIA4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 140 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112779303-A | Method for synthesizing orotic acid by biological enzyme method | 华东理工大学 | 2021-05-11 | — | — | CN | claimed |
| US-7320877-B1 | Dihydroorotase extracted from plants | BASF AKTIENGESELLSCHAFT (DE) | 2008-01-22 | — | — | US | claimed |
| US-20030096741-A1 | Enhanced mineral delivery | SLATTERY CHARLES W (US) | 2003-05-22 | — | — | US | claimed |
| EP-1301787-A2 | METHOD FOR DETECTING URACIL BIOSYNTHESIS INHIBITORS AND THEIR USE AS HERBICIDES | BASF AKTIENGESELLSCHAFT (DE) | 2003-04-16 | — | — | EP | claimed |
| US-20020058244-A1 | Method for detecting uracil biosynthesis inhibitors and their use as herbicides | BASF AKTIENGESELLSCHAFT (DE) | 2002-05-16 | — | — | US | claimed |
| WO-2002006512-A2 | METHOD FOR DETECTING URACIL BIOSYNTHESIS INHIBITORS AND THEIR USE AS HERBICIDES | BASF AKTIENGESELLSCHAFT (DE) | 2002-01-24 | — | — | WO | claimed |
| US-12590322-B2 | Devices and methods for mitochondria replacement and for generating cellular therapeutics | NanoCav, LLC (US) | 2026-03-31 | — | — | US | disclosed |
| EP-4687871-A1 | TOPICAL PALA THERAPY FOR CANCER | The Cleveland Clinic Foundation (US) | 2026-02-11 | — | — | EP | disclosed |
| WO-2025202415-A1 | DHODH INHIBITORS FOR USE IN THE CHRONOPHARMACOLIGICAL TREATMENT AND PREVENTION OF OBESITY AND OBESITY-RELATED METABOLIC DISORDERS | Institut National de la Santé et de la Recherche Médicale (FR) | 2025-10-02 | — | — | WO | disclosed |
| CN-119286751-B | Genetically engineered bacterium for producing uridine diphosphate glucose, construction method and application thereof | 诸城市浩天药业有限公司 | 2025-03-18 | — | — | CN | disclosed |
| CN-119391619-A | Engineering strain for producing uridine diphosphate, construction method and method for synthesizing rebaudioside M | 诸城市浩天药业有限公司 | 2025-02-07 | — | — | CN | disclosed |
| CN-119286751-A | Genetically engineered bacterium for producing uridine diphosphate glucose, construction method and application thereof | 诸城市浩天药业有限公司 | 2025-01-10 | — | — | CN | disclosed |
| WO-2024206402-A1 | TOPICAL PALA THERAPY FOR CANCER | THE CLEVELAND CLINIC FOUNDATION (US) | 2024-10-03 | — | — | WO | disclosed |
| WO-2000042213-A1 | A NOVEL METHOD FOR DESIGNING PROTEIN KINASE INHIBITORS | THE RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK (US) | 2000-07-20 | — | — | WO | disclosed |
| EP-0458070-A1 | Cytidine analogue resistance gene DNA and its use | Takeda Chemical Industries, Ltd. (JP) | 1991-11-27 | — | — | EP | disclosed |
| US-5041542-A | Antitumor-anticarcinogenic agents | NUCLEIC ACID RESEARCH INSTITUTE (US) | 1991-08-20 | — | — | US | disclosed |
| US-4873228-A | 2-oxo-4-carboxy-pyrimidines and their use as anti-malaria and anti-cancer agents | THE UNIVERSITY OF MELBOURNE (AU) | 1989-10-10 | — | — | US | disclosed |
| EP-0260057-A2 | 2-Oxo-4-carboxy-pyrimidines | THE UNIVERSITY OF MELBOURNE (AU) | 1988-03-16 | — | — | EP | disclosed |
| US-4550186-A | ANTITUMOR, ANTILIPEMIC, ANTIINFLAMMATORY, AND ANTIARTHRITIC AGENTS | DUKE UNIVERSITY (US) | 1985-10-29 | — | — | US | disclosed |
| US-4164447-A | TRANSFERS A CARBAMOYL GROUP TO 3-HYDROXYMETHYL CEPHALOSPORIN | GLAXO LABORATORIES LIMITED (GB) | 1979-08-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020058244-A1 | Method for detecting uracil biosynthesis inhibitors and their use as herbicides | UMPS, UGP2, UNG | TDP1 542/4885SLC22A6 2601/4885GABRR1 3905/4885 |
| US-12590322-B2 | Devices and methods for mitochondria replacement and for generating cellular therapeutics | TFAM, TIMM9, MCU | TDP1 874/4885SLC22A6 367/4885GABRR1 2546/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.